Evaluating the Risk of Atherosclerotic Cardiovascular Disease in Inflammatory Skin Disease: Insights From a TriNetX Cohort Study
Journal of Drugs in Dermatology · 2025
DOI: 10.36849/jdd.9380 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Neal Gupta und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Psoriasis, Atherosclerosis, Dermatitis, Atopic, Hidradenitis Suppurativa. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Zitieren
APA
Gupta, N., Zafar, K., Wang, J., Rawal, S., Ray, M., Shayya, A., McGinnis, S., Cohen, M., & Jagdeo, J. (2025). Evaluating the Risk of Atherosclerotic Cardiovascular Disease in Inflammatory Skin Disease: Insights From a TriNetX Cohort Study. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9380
Vancouver
Gupta N, Zafar K, Wang J, Rawal S, Ray M, Shayya A, et al. Evaluating the Risk of Atherosclerotic Cardiovascular Disease in Inflammatory Skin Disease: Insights From a TriNetX Cohort Study. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.9380
BibTeX
@article{Gupta2025,
author = {Gupta, Neal and Zafar, Kayla and Wang, Jennifer and Rawal, Soham and Ray, Maile and Shayya, Ashley and McGinnis, Sandra and Cohen, Marc and Jagdeo, Jared},
title = {Evaluating the Risk of Atherosclerotic Cardiovascular Disease in Inflammatory Skin Disease: Insights From a TriNetX Cohort Study},
journal = {Journal of Drugs in Dermatology},
year = {2025},
doi = {10.36849/jdd.9380}
}
EUVIMED